Related references
Note: Only part of the references are listed.Virtual Crossmatch Approach to Maximize Matching in Paired Kidney Donation
P. Ferrari et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor-Specific Antibodies (DSA)
A. Loupy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation
Stanley C. Jordan et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2011)
Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications
R. J. Duquesnoy
TISSUE ANTIGENS (2011)
Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations
Patrizia Amico et al.
TRANSPLANT INTERNATIONAL (2011)
Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition
R. Carlin Walsh et al.
TRANSPLANTATION (2011)
HLA and MICA: Targets of Antibody-Mediated Rejection in Heart Transplantation
Qiuheng Zhang et al.
TRANSPLANTATION (2011)
Renal Transplantation Across HLA and ABO Antibody Barriers: Integrating Paired Donation into Desensitization Protocols
R. A. Montgomery
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Eculizumab, Bortezomib and Kidney Paired Donation Facilitate Transplantation of a Highly Sensitized Patient Without Vascular Access
B. E. Lonze et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Efficacy of Induction Therapy with ATG and Intravenous Immunoglobulins in Patients with Low-Level Donor-Specific HLA-Antibodies
K. Baechler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Peritransplant Immunoadsorption for Positive Crossmatch Deceased Donor Kidney Transplantation
G. Bartel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies
R. Sberro-Soussan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantation
Emeline Masson et al.
HUMAN IMMUNOLOGY (2010)
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Carmen Lefaucheur et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons
Xavier Tillou et al.
KIDNEY INTERNATIONAL (2010)
Sensitized renal transplant recipients: current protocols and future directions
James Gloor et al.
NATURE REVIEWS NEPHROLOGY (2010)
Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat
Regina Vogelbacher et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Prophylactic Eculizumab after Renal Transplantationin Atypical Hemolytic-Uremic Syndrome.
Lothar Bernd Zimmerhackl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Kidney Paired Donation in Live-Donor Kidney Transplantation
Adam W. Bingaman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of the Proteasome Inhibitor Bortezomib on Humoral Immunity in Two Presensitized Renal Transplant Candidates
Markus Wahrmann et al.
TRANSPLANTATION (2010)
Efficacy of Eculizumab in the Treatment of Recurrent Atypical Hemolytic-Uremic Syndrome After Renal Transplantation
Carlos Fernandez-de Larrea et al.
TRANSPLANTATION (2010)
C4d-Fixing Capability of Low-Level Donor-Specific HLA Antibodies Is Not Predictive for Early Antibody-Mediated Rejection
Gideon Hoenger et al.
TRANSPLANTATION (2010)
An Integrative Approach for the Transplantation of High-Risk Sensitized Patients
Christian Morath et al.
TRANSPLANTATION (2010)
Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study
Alexandre Loupy et al.
TRANSPLANTATION (2010)
Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection
R. Carlin Walsh et al.
TRANSPLANTATION (2010)
Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
Ashley A. Vo et al.
TRANSPLANTATION (2010)
Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients
Nancy L. Reinsmoen et al.
TRANSPLANTATION (2010)
Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure
Robert S. Gaston et al.
TRANSPLANTATION (2010)
The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody-Mediated Rejection
J. E. Locke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production
D. K. Perry et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Mechanisms of Alloantibody Production in Sensitized Renal Allograft Recipients
M. D. Stegall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
C. Lefaucheur et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Subclinical Rejection in Stable Positive Crossmatch Kidney Transplant Patients: Incidence and Correlations
E. S. Kraus et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
G. Einecke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Impact of rituximab therapy for treatment of acute humoral rejection
Z. Kaposztas et al.
CLINICAL TRANSPLANTATION (2009)
Utility of the virtual crossmatch in solid organ transplantation
Patrizia Amico et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2009)
Prospects and limitations of post-transplantation alloantibody detection in renal transplantation
Georg A. Boehmig et al.
HUMAN IMMUNOLOGY (2009)
Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival
George Vlad et al.
HUMAN IMMUNOLOGY (2009)
Using real data for a virtual crossmatch
Andrea A. Zachary et al.
HUMAN IMMUNOLOGY (2009)
Review article: Luminex technology for HLA antibody detection in organ transplantation
Brian D. Tait et al.
NEPHROLOGY (2009)
Plasmapheresis and Intravenous Immunoglobulin in Early Antibody-Mediated Rejection of the Renal Allograft: A Single-Center Experience
Janka Slatinska et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2009)
Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients
Markus Wahrmann et al.
TRANSPLANT INTERNATIONAL (2009)
Bortezomib Can Suppress Activation of Rapamycin-Resistant Memory T Cells Without Affecting Regulatory T-Cell Viability in Non-Human Primates
Jung-Sik Kim et al.
TRANSPLANTATION (2009)
Successful Deceased-Donor Kidney Transplantation in Crossmatch-Positive Patients With Peritransplant Plasma Exchange and Rituximab
Joerg H. M. Beimler et al.
TRANSPLANTATION (2009)
Detection of Immunoglobulin G Human Leukocyte Antigen-Specific Alloantibodies in Renal Transplant Patients Using Single-Antigen-Beads is Compromised by the Presence of Immunoglobulin M Human Leukocyte Antigen-Specific Alloantibodies
Vasilis Kosmoliaptsis et al.
TRANSPLANTATION (2009)
Living Donor Kidney Transplantation Across Positive Crossmatch: The University of Illinois at Chicago Experience
James J. Thielke et al.
TRANSPLANTATION (2009)
Enhanced Kidney Allocation to Highly Sensitized Patients by the Acceptable Mismatch Program
Frans H. J. Claas et al.
TRANSPLANTATION (2009)
Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-Beads
Patrizia Amico et al.
TRANSPLANTATION (2009)
Abrogation of Anti-HLA Antibodies via Proteasome Inhibition
Hargovind L. Trivedi et al.
TRANSPLANTATION (2009)
Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
Thomas Fehr et al.
TRANSPLANTATION (2009)
Long-Term Experience of Plasmapheresis in Antibody-Mediated Rejection in Renal Transplantation
C. M. Brown et al.
TRANSPLANTATION PROCEEDINGS (2009)
Posttransplant HLA Alloreactivity in Stable Kidney Transplant Recipients-Incidences and Impact on Long-Term Allograft Outcomes
G. Bartel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Banff 07 classification of renal allograft pathology: Updates and future directions
K. Solez et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Dampening Ab responses using proteasome inhibitors following in vivo B cell activation
Paolo Cascio et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
Kirsten Neubert et al.
NATURE MEDICINE (2008)
Rituximab and intravenous immune globulin for desensitization during renal transplantation
Ashley A. Vo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Renal transplantation in patients with positive lymphocytotoxicity crossmatches: One center's experience
Colm C. Magee et al.
TRANSPLANTATION (2008)
Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy
Nancy L. Reinsmoen et al.
TRANSPLANTATION (2008)
Natural Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males
Luis E. Morales-Buenrostro et al.
TRANSPLANTATION (2008)
Successful Treatment of Chronic Antibody-Mediated Rejection With IVIG and Rituximab in Pediatric Renal Transplant Recipients
Heiko Billing et al.
TRANSPLANTATION (2008)
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
Matthew J. Everly et al.
TRANSPLANTATION (2008)
Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: Resolution of rejection in the presence of circulating donor-specific antibody
Rob Higgins et al.
TRANSPLANTATION (2007)
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause
B. Sis et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction
J. C. Scornik et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Rituximab therapy for acute humoral rejection after kidney transplantation
Stanislas Faguer et al.
TRANSPLANTATION (2007)
The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection
J. E. Locke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts
M. Haas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Successful rescue of refractory, severe antibody mediated rejection with splenectomy
Bruce Kaplan et al.
TRANSPLANTATION (2007)
Immunoadsorption in severe C4d-positive acute kidney allograft rejection:: A randomized controlled trial
G. A. Boehmig et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis
Robert B. Colvin
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay
Smita Vaidya et al.
TRANSPLANTATION (2006)
Chronic antibody mediated rejection of renal allografts: Pathological, serological and immunologic features in nonhuman primates
R. N. Smith et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation
J. M. Gloor et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation
Alessio Nencioni et al.
BLOOD (2006)
Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy
Christoph Schwarz et al.
WIENER KLINISCHE WOCHENSCHRIFT (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
B Blanco et al.
BLOOD (2006)
A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody
MD Stegall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial
PI Terasaki et al.
TRANSPLANTATION (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Polyclonal rabbit antithymocyte globulin triggers B-Cell and plasma cell apoptosis by multiple pathways
MS Zand et al.
TRANSPLANTATION (2005)
Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies
AI Colovai et al.
HUMAN IMMUNOLOGY (2005)
Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies
G Opelz
LANCET (2005)
Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin
AA Zachary et al.
HUMAN IMMUNOLOGY (2005)
Peritransplant immuno adsorption:: A strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients
M Lorenz et al.
TRANSPLANTATION (2005)
Combined therapy of deoxyspergualin and plasmapheresis: A useful treatment for anti body-mediated acute rejection after kidney transplantation
M Nojima et al.
TRANSPLANTATION PROCEEDINGS (2005)
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection
D Dragun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Novel rescue therapy for C4d-positive acute humoral renal allograft rejection
M Li et al.
CLINICAL TRANSPLANTATION (2005)
Intravenous immunoglobulin treatment in a kidney transplant patient with chronic allograft nephropathy
E Akalin et al.
TRANSPLANTATION (2005)
Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: a report of three cases
H Koller et al.
TRANSPLANT INTERNATIONAL (2004)
The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: Short waiting time and excellent graft outcome
FHJ Claas et al.
TRANSPLANTATION (2004)
Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation
JM Gloor et al.
TRANSPLANTATION (2004)
Evaluation of intravenous immunoglobulin as are agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIHIG02 trial
SC Jordan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation
KJ Tinckam et al.
HUMAN IMMUNOLOGY (2004)
Rituximab as treatment for refractory kidney transplant rejection
YT Becker et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Treatment of C4D-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin
A Shah et al.
TRANSPLANTATION (2004)
Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients
SC Jordan et al.
TRANSPLANTATION (2003)
Humoral theory of transplantation
PI Terasaki
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection
PN Rocha et al.
TRANSPLANTATION (2003)
Plasmapheresis as rescue therapy in accelerated acute humoral rejection
KA Abraham et al.
JOURNAL OF CLINICAL APHERESIS (2003)
Plasmapheresis in C4d-positive acute humoral rejection following kidney transplantation: A review of 4 cases
A Lennertz et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2003)
All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies
PC Lee et al.
TRANSPLANTATION (2002)
Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries:: A contribution of humoral immunity to chronic allograft rejection
H Regele et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Desensitization and subsequent transplantation kidney transplantation of patient using intravenous immunoglobulins (IVIg)
D Glotz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Peri-operative immunoadsorption in sensitized renal transplant recipients
M Haas et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection
H Regele et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
A proteasome inhibitor effectively prevents mouse heart allograft rejection
HY Luo et al.
TRANSPLANTATION (2001)
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection
TP Theruvath et al.
TRANSPLANTATION (2001)
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics
M Crespo et al.
TRANSPLANTATION (2001)
A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection
DH Casadei et al.
TRANSPLANTATION (2001)
A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants
EJ Schweitzer et al.
TRANSPLANTATION (2000)
Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients
RA Montgomery et al.
TRANSPLANTATION (2000)
Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft
GA Böhmig et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)